A Randomized Phase 2 Trial of 177Lu Radiolabeled Anti-PSMA Monoclonal Antibody J591 in Patients With High-Risk Castrate Biochemically Relapsed Prostate Cancer

Abstract

Clinical trial has received WCMC IRB and CTSC approval with enrollment of initial 6 subjects at WCMC. An additional 38 subjects enrolled (29 treated) at participating sub-sites. Reports submitted to WCMC DSMB in December 2014 with approval to proceed without modifications.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Sep 01, 2015
Accession Number
ADA623383

Entities

People

  • Scott T Tagawa

Organizations

  • Cornell University

Tags

DTIC Thesaurus Topics

  • Antibodies
  • Biological Sciences
  • Biomedical Research
  • Clinical Trials
  • Contracts
  • Department Of Defense
  • Diseases And Disorders
  • Electronic Mail
  • Epithelial Cells
  • Health Services
  • Institutional Review Board
  • Medical Personnel
  • Molecules
  • Neoplasms
  • New York
  • Prostate
  • Prostate Cancer

Readers

  • Clinical Trial Research.
  • Oncology (Cancer Research).